We also observed an ~2-fold increased A[beta]42:A[beta]40 ratio, although not statistically  significant,  in brain homogenates from patients 142, 177, 593 and  79/95, carrying the PSEN1 intron 4 mutation, compared with  the A[beta]42:A[beta]40  ratio in healthy controls and in sporadic AD patients
